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Conventional radiography and computed
tomography of cardiac assist devices
Abstract Patients intended for circu-
latory support by cardiac assist
devices (CAD) usually suffer from
end-stage acute or chronic heart
failure. Since the introduction of CAD
in 1963 by DeBakey and coworkers,
the systems have gone through a
substantial evolution and have been
increasingly used in the intervening
decades. The spectrum of CAD
includes a variety of systems serving
to assist the systolic function of the left
ventricle, the right ventricle, or both.
Conventional radiography and multi-
slice spiral computed tomography
(CT) are the most commonly used
radiological techniques for imaging
patients with a CAD. CT is very useful
for evaluating CAD systems by using
both two- and three-dimensional re-
constructions of the volumetric data
sets. The two techniques together
allow for the comprehensive assess-
ment of patients with devices by
imaging the in- and outflow cannulae,
the anastomoses, the position of the
pump, as well as associated compli-
cations. A close collaboration with
cardiac surgeons with expertise in the
field of circulatory support is deemed
necessary for adequate image inter-
pretation. This article describes the
technical diversity of the currently
available CAD systems. The imaging
characteristics on conventional radi-
ography and multislice spiral CT as
well as the typical complications of
their use are demonstrated.
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Introduction
Heart failure, the final common pathway of myocardial
dysfunction in most forms of cardiac disease, is one of the
leading causes of death in developed countries [1]. The
incidence of heart failure has increased by a factor of five in
the past three decades [2]. Most advanced pharmacological
and surgical treatments fail in some patients, and for the
most severe forms of cardiac dysfunction leading to
irreversible biventricular end-stage heart failure, cardiac
transplantation has emerged as the only effective therapy,
affording longevity and quality of life [3]. Implantation of a
totally artificial heart is another option, but requires
complete removal of the native heart [4]. An alternative
technique was introduced by DeBakey and coworkers [5],
who were the first to develop a cardiac assist device
(CAD). A CAD operates as a mechanical circulatory
support system that assists the native heart without needing
its removal [6]. The first application of a CAD was
performed in 1963 in a patient with a postoperative
cardiogenic shock. After CAD implantation, improvement
in the patient’s cardiac function developed after 1 week of
support and the device could be finally removed [5]. In 1971
[7], DeBakey reviewed his experience with this technology
and outlined the lack of a portable control mechanism and
power source as being one of the main barriers to its wider
use. This is understandable because the first CAD systems
were completely or partially paracorporeal and electrically
motor driven. This required a cable (drive line) for the energy
supply and for device control that was located in a small
trolley pulled by the patient [8]. Since their introduction,
CAD systems have undergone a substantial evolution,
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including the development of intracorporeal implants with
percutaneous energy transmission by a small battery
connected with the patient’s belt [9].
Circulatory support systems are able to act as a left
ventricular assist device (LVAD) supporting the left
ventricle, as a right ventricular assist device (RVAD)
supporting the right ventricle, or as a biventricular assist
device (BVAD) supporting both ventricles [10]. Patients
receive mechanical circulatory support by implantation of a
CAD system for one of the three following intentions: (a)
as a bridge-to-transplant that provides circulatory assis-
tance for the patient awaiting heart transplant; (b) as a
bridge-to-recovery that provides circulatory assistance
allowing the heart to recover (mostly from postcardiotomy
cardiogenic shock or myocarditis); or (c) as a long-term
and permanent circulatory assistance, being an alternative
to heart transplantation (so-called destination therapy) [11].
The last indication was documented to be a promising
alternative to heart transplantation in adults [11, 12].
Because of the increasing use of CAD systems,
radiologists are confronted more and more often with
such devices in their daily clinical practice. Therefore,
radiologists need to be familiar with the typical imaging
features of the various CAD systems on conventional
radiography and multislice computed tomography (CT),
the two most frequently used radiological techniques for
imaging these patients, in order to substantiate their role as
cardiovascular specialists [13].
Types of cardiac assist devices
A CAD usually consists of an inflow cannula containing
blood from the ventricle that is assisted by the device. The
inflow cannula connects the assisted ventricle to the pump
where the blood is powered forward into the outflow
cannula. The outflow cannula is a connection between the
pumping element of the CAD and the corresponding great
vessel of the assisted ventricle. The path of the blood flow
can be schematically simplified as follows:
LVAD: left ventricle → inflow cannula → pumping
element → outflow cannula → ascending aorta
RVAD: right ventricle → inflow cannula → pumping
element → outflow cannula → pulmonary trunk
Currently, there are a wide variety of CAD systems
offered by different vendors (Table 1). Early CAD systems
were extensions of the heart–lung machine, which could
drain the blood in a nonpulsatile manner from the heart via
peripheral vascular access to oxygenate the blood extra-
corporeally and return it again to the patient, also called
extracorporeal membrane oxygenation (ECMO) [14]. The
patient was maintained on mechanical ventilation and was
sedated, which limited the use of such systems to
resuscitation after either cardiac arrest or profound shock
[14]. Recent developments have led to devices with
pulsatile blood flow corresponding to the physiology of
the native heart, whereas the latest evolved systems again
show a nonpulsatile axial or centrifugal flow, delivering
continuous blood flow with the advantage of size and
weight reduction and smaller energy demands [15]. The
currently available CAD systems can be categorised into
three generations reflecting the order in which they were
developed and the type of pumping mechanism used [16]
(Table 1).
First-generation pumps Development in the early 1980s
led to CAD systems being smaller than early pumps used
for ECMO. These pumps could generate pulsatile blood
flow through pneumatic or air technology compressing a
reservoir of blood drained from the ventricle. The size of
these devices restricted their use to patients with an
adequate size defined by body surface area to ensure
device location [17]. This type of device can provide
support to the right ventricle, the left ventricle or to both
ventricles. An example is the Berlin Heat Excor (Berlin
Heart AG, Berlin, Germany), a paracorporeal and
pneumatically accentuated pulsatile blood pump, being
one of the first devices designed for the use as a LVAD,
RVAD or BVAD (Fig. 1a). The pneumatic drive line
connects the device to an external portable console. The
paracorporeal external pneumatic pump driver is portable
and allows mobility and ambulant care of the patient.
First-generation pulsatile CAD systems have several
disadvantages, such as their large size and complexity (e.g.
they contain many moving parts, including valves), which
can affect the device’s durability [18]. A study has shown
that pulsatile flow was not able to maintain the integrity of
the pulmonary or systemic circulation as well as the organ
function, whereas other experiments have suggested
Table 1 Overview of the various cardiac assist devices provided by different vendors
First-generation pumps Second-generation pumps Third-generation pumps
HeartMate I (Thermo Cardiosystems,
Inc., Woburn, MA)
Micromed-DeBakey LVAD (MicroMed
Technology, Inc., Houston, TX)
Ventrassist (Ventracor Ltd., Chatswood,
Australia)
Berlin Heat Excor (Berlin Heart AG) Berlin Heart Incor (Berlin Heart AG) HVAD (HeartWare, Miramar, FL)
HeartMate II® (Thoratec, Pleasanton, CA) DuraHeart (Terumo Kabushiki Kaisha
[Terumo Corporation] Shibuya-ku, Japan)
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evidence to the contrary [19]. However, these devices are
still in broad use in many centres because of their
versatility, especially in supporting the right ventricle [8].
An advance in the field of pulsatile devices was the
development of implantable pumps. These devices can be
implanted either preperitoneally or intraperitoneally, with
the inflow to the pump via the left ventricular apex only,
and the outflow graft to the ascending aorta [14]. One of
these devices is the HeartMate® I (Thermo Cardiosystems,
Inc., Woburn, MA, USA) (Table 1).
Second-generation pumps Second-generation CAD sys-
tems are axial-flow pumps with continuous blood flow.
They are considerably smaller and safer because of only
one moving part, which is the rotor generating the blood
flow. These systems are expected to have a greater
durability than first-generation devices. Experience with
these devices, e.g. Micromed-DeBakey LVAD (MicroMed
Technology, Inc., Houston, TX), HeartMate II® (Thoratec,
Pleasanton, CA) and Berlin Heart INCOR (Berlin Heart
AG, Berlin, Germany), is increasing [20, 21] (Table 1).
The Berlin Heart Incor (Berlin Heart AG) (Fig. 3a) weighs
200 g and is one of the latest developments in the field of
CAD systems designed to work as an LVAD. Remarkably,
the continuous blood flow and relative lack of pulsatility
appears to be well tolerated, but longer periods of follow-
up are required to confirm this finding [16]. The
Micromed-DeBakey (MicroMed Technology, Inc., Hous-
ton, TX) is an implantable axial-flow, nonpulsatile pump
with a weight below 100 g (Fig. 4a).
Fig. 1 A 51-year-old male patient who underwent surgery for a
Berlin Heart Excor intended to work as a BVAD for bridge-to-
transplant. a Photograph of the Berlin Heart Excor, ex vivo. The
device has two connections for the inflow (green arrow) and
outflow (red arrow) cannulae. Additionally, the adapter for the
pneumatic drive line (blue arrow) is visible. One Berlin Heart Excor,
such as illustrated, supports one ventricle. b The CT depicts the two
extracorporeally located Berlin Heart Excor pumps (white arrows)
and the inflow (green arrows) and outflow (red arrows) cannulae.
Note the pneumatic drive line (blue arrows). The four cannulae
positions can be inferred from their radiopaque stabilising wires
(black arrows). c Chest radiography in a lateral projection depicting
the radiopaque stabilising wires (arrows) entering the thoracic cavity
through the upper abdominal wall. d Axial thin-slab maximum
intensity projection of the computed tomography data set at the level
of the ascending aorta (Ao) and pulmonary trunk (TP) demonstrating
intact anastomoses of the outflow cannulae (arrows) connecting
the Berlin Heart Excor with the aorta and the pulmonary trunk. Note
the additional Gore-Tex graft connecting the innominate vein to the
right atrium (arrowhead) in this patient. e Oblique axial thin-slab
maximum intensity projection of the computed tomography data set
at the level of the left (LA) and right (RA) atrium, demonstrating the
intact positions of the inflow cannulae (arrows) connecting the CAD
to both atria. f Three-dimensional volume rendered computed
tomography image in an anterior view provides an overview
regarding the complex postsurgical anatomy of the native heart and
illustrates the cannulae with their anastomoses (arrows) and the
Gore-Tex graft connecting the innominate vein to the right atrium
(arrowhead). g Three-dimensional volume rendered computed
tomography image in an anterior view illustrates the course of the
in- and outflow cannulae entering the thoracic cavity via the upper
abdominal wall
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Third-generation pumps One of the most promising
inventions in CAD technology was the development of
centrifugal pumps. These devices are smaller in size
compared with pulsatile CAD systems with simplification
of their implantation that extends their application to
children and small adults [22, 23]. Centrifugal pumps
generate continuous, nonphasic blood flow. The current
third-generation pumps are thought to last approximately
5 years and their performance is currently being evaluated
in several phase I studies involving the Ventrassist®
(Ventracor Ltd., Chatswood, Australia) and HVAD®
(HeartWare, Miramar, FL) devices, and more recently
the DuraHeart® (Terumo Kabushiki Kaisha [Terumo
Corporation] Shibuya-ku, Japan) system [16] (Table 1).
Patient selection
The selection of the CAD depends on the type of heart
failure and on the overall severity of the heart disease
representing the most important factors in the outcome of
patients with CAD [24]. Similar to heart transplantation,
the indication for placement of a CAD is an end-stage heart
failure that is refractory to maximum medical drug therapy
and without consideration of conventional heart surgery or
other catheter techniques (e.g. cardiac valvular disease or
arrhythmia). It is important to mention that CAD surgery is
only the second choice in the absence of an available donor
heart because some patients will qualify for CAD but not
for heart transplantation. For example, patients with
contraindications for immunosuppression, of age higher
than 65 years, severe peripheral vascular disease, and
severe pulmonary emphysema are precluded from heart
transplantation, but may be candidates for CAD [11].
Patients
Between 1999 and 2007, 43 patients underwent surgery for
a CAD at the Clinic for Cardiovascular Surgery of our
hospital. Of these 43 patients, 13 (2 women, 11 men; mean
age 46.2±9.9 years, range 18–54 years) with an extra- or
intracorporeal CAD underwent conventional radiography
and CT at our institute. The 13 patients suffered from end-
stage acute (n=4) or chronic (n=9) heart failure before
surgery (Table 2). Preoperative underlying heart disease
was cardiomyopathy in 12 patients (4 ischaemic, 5
dilatative, 1 idiopathic, 1 following surgery for congenital
transposition of the great arteries in childhood, and 1
restrictive cardiomyopathy due to myocardial amyloido-
sis). All the patients in this group (n=12) were awaiting a
cardiac transplant and received a CAD intended for bridge-
to-transplant. One patient underwent surgery for a CAD
intended for bridge-to-recovery following heart transplan-
tation. CT is not routinely performed in patients after CAD
implantation, but only in those in whom complications are
suspected. All these 13 patients underwent a chest CT, 4 of
whom had an additional abdominal CT. The reasons for
referral to chest CT were suspected pneumonia, device
thrombosis or malpositioning, pseudoaneurysm formation
at the anastomosis site, embolism, haematoma or dissection
(Table 2).
CT protocol
All CT examinations were performed using multislice
spiral CT systems (Table 3). In five patients a 4-slice CT
system was used (Volume Zoom, Siemens Medical
Solutions, Forchheim, Germany), in three patients a 16-
slice CT system (Sensation 16, Siemens), and in five
Table 2 Patients’ demographic data, types of assist devices,
indications for device implantation and causes of referral to
computed tomography
Patients 13
Mean age ± SD (years) 46.2±9.9
Gender
Male 11
Female 2
Indication for CAD
Dilatative cardiomyopathy 5
Ischaemic cardiomyopathy 4
Idiopathic cardiomyopathy 1
Restrictive cardiomyopathy 1
Congenital heart disease 1
Dysplastic right ventricular cardiomyopathic 1
Arrhythmia and heart transplantation
Intention for CAD
Bridge-to-transplant 12
Bridge-to-recovery 1
Type of CAD
Micromed-DeBakey LVAD 6
Berlin Heart Incor 5
Berlin Heart Excor BVAD 1
Berlin Heart Excor RVAD 1
Causes of referral to CT
Infection 6
Device malpositioning 4
Pseudoaneurysm at anastomosis site 4
Pneumonia 4
Embolism 3
Thrombosis 3
Aortic dissection 1
Haematoma 1
SD standard deviation, CAD cardiac assist device, LVAD left
ventricular assist device, RVAD right ventricular assist device, BVAD
biventricular assist device, CT computed tomography
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patients a 64-slice CT system (Sensation 64, Siemens). We
acquired unenhanced images as well as imaging in arterial
and venous phases after intravenous administration of non-
ionic, iodinated contrast media (Ultravist 300, 300 mg/ml,
Bayer Schering Pharma, Berlin, Germany). The beginning of
the arterial phase was controlled by bolus tracking after
placing a region of interest (ROI) in the proximal descending
aorta. With the 4-slice CT system, image acquisition started
after the predefined threshold of 100 Hounsfield units (HU)
was reached; with the 16- and 64-slice CT systems the
threshold was set to 140 HU. The venous phase was
performed 80 s after initiation of contrast medium injection.
All images were reconstructed using a soft-medium tissue
kernel (B30f) and a hard-sharp bone kernel (B50f).
Parameters are detailed in Table 3.
Imaging findings
For the evaluation of the CAD systems, various postpro-
cessing techniques of the CT data sets were used. These
included multiplanar reformations (MPR), maximum in-
tensity projections (MIP) and volume rendering (VR).
Postprocessing in our patients was performed on an
external workstation (Multimodality Workplace, Siemens)
Table 3 CT parameters for the arterial and the venous phase of contrast enhancement
Systemsa Arterial phase Venous phase
Slice thickness/
increment
kV/mAsa Collimation CM amount/
delay
Slice thickness/
increment
kV/mAsa Collimation CM amount/
delay
4-detector row
CT (n=5)
2.0/1.0 120/180 4×1.0 160/bolus tracking 3.0/2.0 120/180 4×1.0 160/80 s
16-detector row
CT (n=3)
1.5/1.0 120/180 16×0.75 140/bolus tracking 2.0/1.0 120/180 16×0.75 140/80 s
64-slice CT (n=5) 1.0/0.8 120/180 64×0.6b 140/bolus tracking 2.0/1.5 120/180 64×0.6b 140/80 s
kV kilo voltage, mAs tube current–time product, CM contrast media
aAutomated tube current modulation was routinely used in all patients
bZ-flying spot
3Fig. 2 A 61-year-old male patient who underwent surgery for a
Berlin Heart Excor RVAD as a bridge-to-recovery. a The CT depicts
the Berlin Heart Excor pump that is located extracorporeally (white
arrow), as well as the inflow (green arrow) and outflow cannulae
(red arrow). The pneumatic drive line of the CAD is also shown
(blue arrow). The radiopaque stabilising wires delineate the in- and
outflow cannulae in their course through the upper abdominal wall
into the thoracic cavity. Note bilateral pacemaker devices (arrow-
heads) and electrodes. b Axial computed tomography image
demonstrates intact anastomosis (arrow) connecting the outflow
cannula to the pulmonary trunk (TP). c Axial computed tomography
reconstruction at the level of the right atrium (RA) demonstrates an
intact position of the inflow cannula at the right atrium (arrow). d
Three-dimensional volume rendered computed tomography image
in a left anterior oblique view provides an overview of the heart
including the right (RV) and left (LV) ventricle, as well as the
outflow cannula (arrow) connected to the pulmonary trunk (TP). e
Three-dimensional volume rendered computed tomography image
in a left posterior oblique demonstrates the inflow cannula (arrow)
connected to the right atrium (RA). The left atrium (RA) and the
superior vena cava (SVC) are also shown
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equipped with postprocessing software (Syngo InSpace4D,
Siemens).
Berlin Heart Excor
In the patients with a Berlin Heart Excor, conventional
radiography (both chest radiography and CT scanogram)
allowed for the delineation of the wire-directed in- and
outflow cannulae that were placed depending on the type of
assistance (BVAD or RVAD, Figs. 1b, c and 2a). The
cannulae exit the upper abdominal wall and are connected
to the paracorporeally placed blood pump. The pneumatic
drive line could be visualised in all patients. Use of
postprocessed images with CT allowed for the accurate
depiction of the CAD and the native anatomy of the heart
and adjacent soft tissue structures, lung and osseous
thoracic cage. In the patient with a Berlin Heart Excor
BVAD, the outflow cannula in the pulmonary artery and
ascending aorta as well as the inflow cannula in the right
and left atrium could be clearly visualised (Fig. 1d, e). In
the patient with a Berlin Heart Excor RVAD, the inflow
cannula connected to the right atrium and the outflow
cannula connected to the pulmonary artery could be
Fig. 3 A 58-year old male patient with a Berlin Heart Incor LVAD
as a bridge-to-transplant. a Photograph of a Berlin Heart Incor
LVAD, ex vivo, designed for use as an LVAD. The connections for
the inflow (green arrow) and the outflow (red arrow) cannulae are
depicted; access for the drive line for control and energy supply of
the pump is also visible (orange arrow). b Chest radiography in a
posteroanterior projection shows the inflow (green arrow) and
outflow (red arrow) cannulae as well as the pump (thick black
arrow), which is located intrapericardially. The radiopaque inflow
cannula to the left ventricle (thin black arrow) and the spring lock of
the outflow cannula (double arrow) are also depicted. The drive line
for control and energy supply of the pump exits through the left
upper abdominal wall (orange arrow). In this patient, the left upper
abdominal quadrant was chosen for the drive line exit, as the right
upper abdominal quadrant, which is usually used, was occupied by
an artificial bowel stoma. Note the small loculated pleural effusion
in the horizontal fissure (arrowhead). c Chest radiography in a
lateral projection depicts the radiopaque Berlin Heart Incor device
located in the pericardial cavity (thick black arrow), the inflow
cannula of the left ventricle (green arrow), the energy supply cable
(orange arrow) and the spring lock of the outflow cannula (double
arrow). Note the mechanical mitral valve prosthesis (arrowhead). d
Oblique sagittal computed tomography reconstruction at the level of
the ascending aorta (Ao) demonstrates intact anastomoses (thick
white arrow) of the outflow cannula connecting the pump to the
ascending aorta. Note the spring lock (black arrow) at the outflow
cannula and the severe metallic artefacts (thin white arrows) evoked
by the Berlin Heart Incor (not shown). e Oblique coronal computed
tomography reconstruction at the level of the left ventricular apex
demonstrates the Berlin Heart Incor with the connections of the
inflow (white arrow) and outflow (black arrow) cannulae. f Oblique
axial computed tomography reconstruction at the level of the
ascending aorta (Ao) and the left ventricle (LV) demonstrate intact
anastomoses of the cannulae connecting the pump to the apex of the
heart (black arrow) and the ascending aorta (white arrow). g Three-
dimensional volume rendered computed tomography image in an
anterior view illustrating the course and positions of the in- and
outflow cannulae, the Berlin Heart Incor (double arrow) and the
native heart with the right (RV) and left (LV) ventricle. The
anastomoses are connecting the pump to the apex of the heart
(arrowhead) and the ascending aorta (arrow)
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accurately depicted (Fig. 2b, c). The course of the in- and
outflow cannulae exiting the upper abdominal wall as well
as the connection to the pumps were demonstrated by CT
using the VR technique (Figs. 1f, g and 2d, e).
Berlin Heart Incor
The intracorporeal position of the Berlin Heart Incor could
be demonstrated by conventional radiography (Fig. 3b, c)
in two projections as well as the in- and outflow cannulae
that were placed in the left ventricle and ascending aorta.
CT showed the inflow conduit that was placed in the left
ventricular apex, and the outflow conduit that was sutured
onto the ascending aorta (Fig. 3d–f). The implantable pump
housing was placed inside the pericardial cavity and the
drive line exited the abdominal wall through the right upper
quadrant. The connection to the pumps could be depicted
by using VR images (Fig. 3g).
Micromed-DeBakey
Both the device and the cannulae positions of the
Micromed-DeBakey LAVD were depicted by conventional
radiography (Fig. 4b, c). In the patients with a Micromed-
DeBakey LVAD, the inflow cannula was placed in the left
ventricular apex and the outflow graft was sutured onto the
ascending or descending aorta which can be demonstrated
by CT (Fig. 4d–f). The blood pump was placed in the
pericardium with little extension into the abdominal wall,
and the drive line exited the skin through the right upper
abdominal quadrant.
Analysis of image techniques
MPR of CT data generate images of structures that follow
an oblique course to the axial plane. This is particularly
useful for the illustration of in- and outflow cannulae of the
Fig. 4 A 54-year-old patient who underwent surgery for an
intracorporeally placed Micromed-DeBakey LVAD as a bridge-to-
transplant. a Photograph of the Micromed-DeBakey LVAD, ex vivo.
The connections for the inflow cannula (green arrow) and the
outflow graft (red arrow), as well as the pumping element (double
arrow) and the drive line for control and energy supply (orange
arrow), are depicted. The flow sensor of the Micromed-DeBakey
LVAD is also shown (arrowhead). b Chest radiography in a
posteroanterior projection depicts the inflow cannula (green arrow)
and the CAD (double arrow) located in the intrapericardial cavity.
Note also the radiopaque flow sensor placed around the outflow
graft (arrowhead). c Chest radiography in a lateral projection depicts
the outflow cannula (green arrow) and the flow sensor placed
around the outflow graft (double arrow) located in the intrapericar-
dial cavity. The drive line (orange arrow) for control and energy
supply of the pump exits the skin in the right upper abdominal wall.
d Oblique sagittal computed tomography reconstruction at the level
of the ascending aorta (Ao) and the left (LV) and right (RV) ventricle
demonstrates an intact anastomosis of the outflow graft of the
DeBakey pump with the ascending aorta (arrow). e Oblique axial
computed tomography reconstruction at the level of the left ventricle
(LV) demonstrates an intact position of the inflow cannula
connecting the DeBakey pump to the apex of the heart (arrow). f
Oblique sagittal computed tomography reconstruction demonstrat-
ing the correct position of the inflow cannula of the DeBakey pump
inside the apex of the left ventricle (arrow)
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CAD systems to the cardiovascular surgeon, because the
plane of the reformatted image can be individually adjusted
to the long axis of the structure of interest.
MIP images are obtained by projecting the highest
attenuation voxels encountered throughout the volume
onto an image plane. It is a technique that facilitates the
evaluation of structures that are not lying in a single plane.
MIP is mainly used for the evaluation of vascular
structures. It has the disadvantage of obscuring vessels
that are adjacent to bones or to radiopaque devices.
While VR is the most time-consuming postprocessing
technique, it is helpful for the three-dimensional visuali-
sation of complex anatomy (Fig. 3g). VR in patients with
CAD systems usually was performed using the data sets
that were reconstructed with a soft-medium tissue recon-
struction filter. Use of a hard-sharp bone filter was superior
in reducing the metallic artefacts of the Incor devices.
In general, we recommend the combined use of the
various postprocessing CT techniques which improves the
comprehensive overall understanding of the cardiovascular
anatomy and therefore potentially reduces the time needed
for a CT-based diagnosis [25]. This holds true, despite the
fact that the greatest amount of structural information, like
the anastomoses of the in- and outflow cannulae, is usually
obtained by MPR alone [26].
In our patients, CT provided a very good and detailed
visualisation of the CAD systems including the position
and anastomosis sites of the in- and outflow cannulae,
which corroborates the results of a previous study [27].
Similar to the work of Knollmann et al. [28], CT was
superior in the evaluation of anastomoses for all devices
compared with conventional radiography. The latter
depicts the in- and outflow cannulae and positioning of
the blood pump itself, but lacks detailed morphologic
information regarding the heart and CAD. On the other
hand, intracorporeally located CAD systems resulted in
considerable metallic artefacts, which limit the diagnostic
quality, especially in the region surrounding the devices
[29].
CT protocol
The CT protocol was chosen according to the respective
indication. If haemorrhage was suspected, we used a three-
phase CT protocol, including an unenhanced image to
allow measurement of CT attenuation in potential fluid
collections. The same protocol was used when pseudoan-
eurysm formation at the anastomosis site or thrombosis of
the device was suspected. We suggest that unenhanced
images are used for visualising the metallic parts of the
CAD systems and to differentiate potential vessel calcifica-
tions from contrast-enhanced structures. The arterial phase
of contrast enhancement was very helpful for the depiction
of the in- and outflow cannulae of the CAD systems and the
great vessels of the heart. The venous phase of contrast
enhancement was added for evaluation of the anastomoses
of the in- and outflow cannulae with regard to possible
pseudoaneurysms or contrast media extravasation. We
advise a single venous phase of contrast enhancement in
those patients for whom the aim was to rule out a focus of
infection. When pneumonia was suspected, only unen-
hanced CTwas performed. From our experience, the use of
a flexible CT imaging protocol adjusted to the individual
clinical indication appears more adequate than using a
fixed three-phase protocol, particularly for avoiding
Fig. 5 A 56-year-old male patient who underwent surgery for an
intracorporeally placed Micromed-DeBakey LVAD as a bridge-to-
transplant. Axial computed tomography reconstruction at the level
of the pulmonary trunk (TP) demonstrates a mediastinal haematoma
(white arrow) surrounding the intact anastomosis of the outflow
cannula, connecting the device to the ascending aorta (black arrow)
Fig. 6 A 47-year-old male patient who underwent surgery for an
intracorporeally placed Berlin Heart Incor as a bridge-to-transplant.
Axial computed tomography reconstruction at the level of the left
(LA) and right (RA) atrium demonstrates an infected fluid collection
in the anterior mediastinum with peripheral contrast enhancement
(white thin arrows). Note the correct positioning of the inflow
cannula (black arrow) in the left ventricle (LV), the outflow graft in
its course to the ascending aorta (thick white arrow), and pacemaker
electrodes in the RA and right ventricle
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unnecessary radiation exposure. Electrocardiography
(ECG) gating was not used in any patient because
evaluation of the coronary arteries was not the focus of
these CT examinations. Nevertheless, when imaging of
coronary arteries or of potential coronary artery bypass
grafts is required, the CT data acquisition should be
synchronised to the ECG. The electrical conduction system
of the native heart is in good order in most of the patients
and works independently from the assist device [29].
Furthermore, the use of ECG synchronisation in patients
with a CAD may improve the image quality by reducing
motion artefacts [29].
Complications
The incidence of complications associated with the
implantation of CAD is approximately 67% and includes
haemorrhage, heart failure, renal dysfunction, infection,
neurological events, thromboembolic events, as well as
thrombosis and air embolism [30, 31]. Device failure can
be life-threatening and requires device exchange. In the
REMATCH study [32], 17% of deaths were caused by
device failure. The mortality in patients requiring BVAD as
a bridge-to-transplant has been reported to be more than
40% in contrast to the 25% mortality of patients bridged on
LVAD [33]. Generally, conventional radiography and CT
are both useful techniques that may aid in the detection of
complications [11, 34], whereas CT is superior in charac-
terisation of these complications such as haemorrhage and
infections.
Haemorrhage
Haemorrhage occurs either as an early event following
surgery or later due to a connection insufficiency.
Haemorrhage may appear as abnormal circumferential
density surrounding a device and/or its cannulae (Fig. 5).
There is evidence that the inner surface of LVAD
contributes to the bleeding tendency of the activating
platelets, along with evidence that LVAD themselves
initiate the activation of the fibrinolytic pathway [34].
Mechanisms that alter the tendency to bleed are routine
anticoagulation, platelet inhibition, hepatic dysfunction
and a poor nutritional status [34]. However, with the Berlin
Heart Excor, it is possible to fully reverse anticoagulation
after implantation that may result in a low incidence of
haemorrhage which has been one of the major surgical
obstacles in the early experience with CAD [35].
Infections
Infectious complications, which are largely caused by the
presence of the drive line across the skin barrier, have been
reported to occur in almost half of the LVAD recipients
[36]. Such complications may occur anywhere along the
device itself and all its conduits and connecting cannulae
and grafts due to fibrin deposits triggering activity of
infecting organisms. Infection may appear as a loculated
fluid collection adjacent to a device part (Fig. 6).
Thromboembolism
A source of embolism may be the pump itself and its
artificial cardiac valves, as well as the native chambers or
valves of the heart. Thromboembolism often causes
neurologic complications.
Conclusions
Patients with end-stage heart failure may receive mechan-
ical circulatory support by implantation of a CAD intended
for bridge-to-transplant, bridge-to-recovery or as a perma-
nent alternative to heart transplantation. CAD therapy is a
continuously evolving field with an increasing number of
implantations over the last 20 years. The Micromed-
DeBakey LVAD, the Berlin Heart Incor LVAD and the
Berlin Heart Excor are frequently implanted artificial blood
pumps. Every CAD has its own footprint that produces a
specific radiological appearance on conventional radiog-
raphy and CT. CT is the modality of choice that
comprehensively allows one to delineate the in- and
outflow cannulae and positioning of the blood pump itself,
as well as potential CAD-associated complications like
mediastinal haemorrhage, infection and thromboembolism.
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